BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 776596)

  • 21. Inhibition of in vivo insulin secretion by prostaglandin E1.
    Robertson RP; Gavareski DJ; Porte D; Bierman EL
    J Clin Invest; 1974 Aug; 54(2):310-5. PubMed ID: 4847247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal by methysergide of inhibition of insulin secretion by prostaglandin E in the dog.
    Robertson RP; Guest RJ
    J Clin Invest; 1978 Nov; 62(5):1014-9. PubMed ID: 361755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatostatin-induced inhibition of insulin secretion from isolated islets of rat pancreas in presence of glucagon.
    Sieradzki J; Schatz H; Nierle C; Pfeiffer EF
    Horm Metab Res; 1975 Jul; 7(4):284-7. PubMed ID: 168138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lethal Escherichia coli septicemia in the baboon: alpha-adrenergic inhibition of insulin secretion and its relationship to the duration of survival.
    Cryer PE; Coran AG; Sode J; Herman CM; Horwitz DL
    J Lab Clin Med; 1972 Apr; 79(4):622-38. PubMed ID: 4401771
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of alpha-adrenoceptor blockade by phentolamine on basal and stimulated insulin secretion in the mouse.
    Ahrén B; Lundquist I
    Acta Physiol Scand; 1985 Oct; 125(2):211-7. PubMed ID: 2866660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Biological properties of synthetic somatostatin].
    Iudaev NA; Fedotov VP; Komolov IS; Morozova LG; Pluzhnikova GN
    Probl Endokrinol (Mosk); 1979; 25(1):75-9. PubMed ID: 368759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-adrenergic stimulation contributes to incretin effect in conscious dogs.
    Chap Z; Okuda Y; Peña J; Field JB
    Am J Physiol; 1991 Jul; 261(1 Pt 1):E58-65. PubMed ID: 1650140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
    Imura H; Kato Y; Ikeda M; Morimoto M; Yawata M
    J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of somatostatin analogues on alpha- and beta-cells of the pancreas.
    Taborsky GJ; Smith PH; Porte D
    Am J Physiol; 1979 Feb; 236(2):E123-8. PubMed ID: 369388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroendocrine control of insulin secretion.
    Lockhart-Ewart RB; Mok C; Martin JM
    Diabetes; 1976 Feb; 25(2):96-100. PubMed ID: 814025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of alpha- and beta adrenergic receptor blockaders on the secretory response of pancreatic beta cells in thyrotoxicosis].
    Zhurova TE; Lugovaia NA; Poltorak VV; Iurchenko MZ
    Ter Arkh; 1982; 54(10):36-9. PubMed ID: 6129711
    [No Abstract]   [Full Text] [Related]  

  • 32. Abolition of dopaminergic insulin secretion by beta-adrenergic antagonism.
    Cyrus J; Stagner J; Samols E
    Endocrinology; 1982 Jul; 111(1):214-8. PubMed ID: 6123430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of adrenergic blockade on the release of insulin, glucagon and somatostatin from the pancreas in response to splanchnic nerve stimulation in cats.
    Andersson PO; Holst J; Järhult J
    Acta Physiol Scand; 1982 Dec; 116(4):403-9. PubMed ID: 6133409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of glucagon and insulin secretion by somatostatin in the rat pancreas perfused in situ.
    Johnson DG; Ensinck JW; Koerker D; Palmer J; Goodner CJ
    Endocrinology; 1975 Feb; 96(2):370-4. PubMed ID: 1089535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biphasic effect of phentolamine on glucose-induced insulin release by pancreatic islets: possible mechanism of action at high concentrations (10(-3) M).
    Porter J; Andrews S; Blackard W
    Res Commun Chem Pathol Pharmacol; 1978 Dec; 22(3):523-34. PubMed ID: 366710
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of corticosterone on insulin and glucagon secretion by the isolated perfused rat pancreas.
    Barseghian G; Levine R
    Endocrinology; 1980 Feb; 106(2):547-52. PubMed ID: 6986256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The interaction between cAMP-dependent and cAMP-independent mechanisms in mediating the somatostatin inhibition of insulin secretion in isolated rat pancreatic islets.
    Malm D; Vonen B; Burhol PG; Florholmen J
    Acta Physiol Scand; 1991 Nov; 143(3):305-10. PubMed ID: 1685288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenous hyperglycemia restores insulin release impaired by somatostatin analogue.
    Taborsky GJ; Porte D
    Am J Physiol; 1981 Apr; 240(4):E407-13. PubMed ID: 6111928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the mechanism of diazoxide-induced hyperglycemia.
    Altszuler N; Moraru E; Hampshire J
    Diabetes; 1977 Oct; 26(10):931-5. PubMed ID: 908462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of glucose on somatostatin secretion from isolated pancreatic islets of normal and streptozotocin-diabetic rats.
    Kanatsuka A; Makino H; Matsushima Y; Osegawa M; Kasanuki J; Miyahira M; Yamamoto M; Kumagai A
    Endocrinology; 1981 Aug; 109(2):652-7. PubMed ID: 6113954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.